Institut Claudius Regaud

This study tested a new, more precise type of radiation therapy (IMRT with a special MRI-guided boost) against standard radiation, both given with the chemotherapy drug temozolomide, for people with glioblastoma, an aggressive brain cancer. The goal was to see if the newer radiat…

This study tested the safety of the cancer drug pazopanib in frail elderly patients (75 and older) with metastatic solid tumors. Researchers aimed to find the highest safe dose by monitoring side effects during the first month of treatment. The study was terminated early after en…